相关实验视频
Updated: Jul 12, 2025

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
在三个专科诊所的唐氏综合征患者中,肺炎疫苗反应
Stephanie L Santoro1,2, Carolyn H Baloh3, Sarah J Hart4
1Down Syndrome Program, Division of Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
患有唐氏综合征的人经常面临呼吸系统问题. 一项新的研究发现,肺炎球菌免疫接种的常见不充分反应,建议对这一群体进行例行标位查.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
- 儿科 儿科 儿科
背景情况:
- 唐氏综合征 (DS) 患者对肺炎等呼吸道感染的易感性增加.
- 在DS中,免疫反应和免疫疗效,特别是关于肺炎球菌疫苗的免疫效果,仍然不完全理解.
- 复发性感染及其与DS中疫苗反应的联系需要进一步调查.
研究的目的:
- 评估临床查仪在预测唐氏综合征患者肺炎球菌免疫反应方面的有效性.
- 评估DS群体中肺炎球菌标位不足的流行率.
- 确定复发性感染与DS患者肺炎球菌抗体水平之间的关联.
主要方法:
- 预期收集患有唐氏综合征的人的肺炎球菌标位和实验室数据.
- 利用11项查来评估潜在的不充分免疫反应预测因素.
- 对23种肺炎球菌血清型的血清型特异性抗体标位分析.
主要成果:
- 这种11项查方法未能准确预测DS患者的肺炎球菌位数不足.
- 唐氏综合征患者中有62% (35人中34人) 的显著比例显示肺炎球菌标位异常.
- 这些异常标位表明对标准肺炎球菌疫苗接种的免疫反应不足或不足.
结论:
- 使用的查器对于识别患有唐氏综合征的个体,有较差肺炎球菌疫苗反应风险,是不有效的.
- 疫苗接种后,高比例的DS患者表现出不充分的抗体水平,这突出了潜在的公共卫生问题.
- 临床医生应考虑在所有唐氏综合征患者中直接查肺炎球菌标位,以确保足够的疫苗诱导免疫力.
更多相关视频
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Vaccinations